By John Halamka and Paul Cerrato - The medical Internet of Things is filled with many valuable devices--and a few questionable ones. It’s critically important to separate clinically validated tools from marketing hype.

By John Halamka and Paul Cerrato - Working “in the cloud” may not be a panacea to solve all your organization’s problems, but the benefits outweigh the risks.

By John Halamka and Paul Cerrato - The Interoperability and data blocking regulations mandated by the 21st Century Cures Act may pose a challenge to providers, IT developers, and health information exchanges, but implementing the rules has the potential to significantly improve patient care.

By John Halamka and Paul Cerrato - Combining genetic sequencing, life-style modification, and personalized drug therapy will transform health care.

By John Halamka and Paul Cerrato - An analysis of over 2 billion lab test results suggests a deep learning model can help create personalized reference ranges, which in turn would enable clinicians to monitor health and disease better.

By John Halamka and Paul Cerrato - AI and machine learning have the potential to redefine the management of several GI disorders.

By John Halamka and Paul Cerrato - We must make a serious commitment to increase financial resources and provide better analytics for real world evidence/real time data in support of public health.

By John Halamka and Paul Cerrato - In addition to evaluating the safety of software as a medical device (SaMD), the agency needs to devote more resources to evaluating its efficacy and quality.

By John Halamka and Paul Cerrato - By providing a safe, secure environment, novel approaches enable health care innovators to share data without opening the door to snoopers and thieves.